INBX — Inhibrx Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Inhibrx Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	129	131	274	278	153
Net Total Accounts Receivable
Net Total Receivables	0.615	0.878	0.257	0.778	0.42
Prepaid Expenses
Total Current Assets	132	139	280	295	160
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	11.3	9.49	7.22	9.37	13.5
Other Long Term Assets
Total Assets	144	150	291	308	181
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	31.4	22.5	27.6	56.3	40.7
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	68.3	98.1	233	264	47.2
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	75.5	52.4	58.1	43.5	134
Total Liabilities & Shareholders' Equity	144	150	291	308	181
Total Common Shares Outstanding